Xpert® MTB/RIF for smear-negative presumptive TB: Impact on case notification in DR Congo

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 2, 2016, Pages 240-246

  Mbonze, N B ^a   Tabala, M ^a   Wenzi, L K ^a   Bakoko, B ^b   Brouwer, M ^c   Creswell, J ^d   Van Rie, A ^e   Behets, F ^e   Yotebieng, M ^e,f  

^a UNIVERSITY OF KINSHASA   (Congo)

^b Provincial Coordination of the National TB Programme   (Congo)

^c Regional Laboratory of Public Health   (Netherlands)

^d Stop TB Partnership   (Switzerland)

^e IL   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

Follow on test; Resource poor settings; TB detection

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DEMOCRATIC REPUBLIC CONGO; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PRIORITY JOURNAL; SPUTUM ANALYSIS; TUBERCULOSIS; TUBERCULOSIS RAPID TEST; ALGORITHM; CASE CONTROL STUDY; CLINICAL PATHWAY; CLINICAL TRIAL; DEVELOPING COUNTRY; DISEASE NOTIFICATION; EPIDEMIOLOGY; EVALUATION STUDY; HEALTH CARE DELIVERY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRESCHOOL CHILD; SPUTUM; TIME FACTOR; TUBERCULOSIS, PULMONARY;

ADOLESCENT; ALGORITHMS; BACTERIOLOGICAL TECHNIQUES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CRITICAL PATHWAYS; DEMOCRATIC REPUBLIC OF THE CONGO; DEVELOPING COUNTRIES; DISEASE NOTIFICATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84954442035     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0177     Document Type: Article

References (19)

1. World Health Organization. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. Geneva, Switzerland: WHO, 2010.
2. Boehme C, Nabeta P, Hillemann D., et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
3. Boehme C.C., Nicol M P, Nabeta P, et al Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
4. World Health Organization. Global tuberculosis report, 2014. WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014.
5. Van Rie A., Fitzgerald D, Kabuya G., et al. Sputum smear microscopy: evaluation of impact of training, microscope distribution, and use of external quality assessment guidelines for resource-poor settings. J Clin Microbiol 2008; 46: 897-901.
6. Martinot A, Van Rie A, Mulangu S, et al Baseline assessment of collaborative tuberculosis/HIV activities in Kinshasa, the Democratic Republic of Congo. Trop Doct 2008; 38: 137-141.
7. World Bank. Congo, Democratic Republic. Washington DC, USA: 2015. http://data.worldbank.org/country/congo-dem-rep. Accessed October 2015.
8. Creswell J, Codlin A, Andre E., et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect Dis 2014; 14: 2.
9. Menzies N.A., Cohen T, Lin H-H, Murray M, Salomon J A. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLOS MED 2012; 9: e1001347.
10. Dowdy D.W., Davis J L, den Boon S, Walter N D, Katamba A, Cattamanchi A. Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa. PLOS ONE 2013; 8: e70485.
11. Cook T.D. Quasi-experimental design. Wiley Encyclopedia of Management. Chichester, UK: John Wiley & Sons, 2015.
12. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
13. Meyer-Rath G., Schnippel K, Long L., et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLOS ONE 2012; 7: e36966.
14. Durovni B, Saraceni V, van den Hof S, et al. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial. PLOS MED 2014; 11: e1001766.
15. World Health Organization. Global health expenditure database. Geneva, Switzerland: WHO, 2012; http://apps.who.int/nha/database/Key-Indicators/Index/en. Accessed October 2015.
16. w MTB/RIF testing on case notifications in Nepal. Int J Tuberc Lung Dis 2015; 19: 545-551.
17. Blok L, Creswell J, Stevens R., et al. A pragmatic approach to measuring, monitoring and evaluating interventions for improved tuberculosis case detection. Int Health 2014; 6: 181-188.
18. Theron G, Zijenah L, Chanda D., et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014; 383: 424-435.
19. Creswell J, Rai B, Wali R., et al. Introducing new tuberculosis diagnostics: the impact of Xpert MTB/RIF testing on case notifications in Nepal. Int J Tuberc Lung Dis 2015; 19: 545-551.